Cortopin 1% w/w Cream

Երկիր: Իռլանդիա

Լեզու: անգլերեն

Աղբյուրը: HPRA (Health Products Regulatory Authority)

Ակտիվ բաղադրիչ:

Hydrocortisone

Հասանելի է:

Pinewood Laboratories Ltd

ATC կոդը:

D07AA; D07AA02

INN (Միջազգային անվանումը):

Hydrocortisone

Դոզան:

1 percent weight/weight

Դեղագործական ձեւ:

Cream

Ռեկվիզորի տեսակը:

Product not subject to medical prescription

Թերապեւտիկ տարածք:

Corticosteroids, weak (group I); hydrocortisone

Լիազորման կարգավիճակը:

Marketed

Հաստատման ամսաթիվը:

1989-07-17

Տեղեկատվական թերթիկ

PATIENT INFORMATION LEAFLET
CORTOPIN 1% W/W CREAM
1% HYDROCORTISONE
READ ALL OF THIS LEAFLET BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR
YOU.
This medicine is available without a prescription. However, you still
need to use this
product carefully to get the best results from it.
•
Keep this leaflet. You may need to read it again.
•
Ask your pharmacist if you need more information or advice.
•
You must contact a doctor if your symptoms worsen or do not improve
after 7
days
•
If any of the side effects gets serious, or if you notice any side
effects not listed in
this leaflet, please tell your doctor or pharmacist.
IN THIS LEAFLET:
1.
What Cortopin 1% w/w Cream is and what it is used for
2.
Before you use Cortopin 1% w/w Cream
3.
How to use Cortopin 1% w/w Cream
4.
Possible side effects
5.
How to store Cortopin 1% w/w Cream
6.
Further information
1. WHAT CORTOPIN 1% W/W CREAM IS AND WHAT IT IS USED FOR
Cortopin 1% w/w Cream is a smooth white cream for application to the
skin only. It
contains hydrocortisone which belongs to a group of medicines called
corticosteroids.
Cortopin 1% w/w Cream is used to reduce inflammation in a variety of
inflammatory
skin conditions, such as:
•
mild to moderate eczema
•
dermatitis caused by irritants or allergens
•
insect bite reactions
Hydrocortisone should not be confused with anabolic steroids, used by
some body
builders and taken as tablets or injections.
2. BEFORE YOU USE CORTOPIN 1% W/W CREAM
DO NOT USE CORTOPIN 1% W/W CREAM:
•
if you are allergic to hydrocortisone or to any of the other
ingredients of Cortopin
1% w/w Cream _(see Section 6 and end of Section 2). _
•
if you have a bacterial infection (e.g. impetigo), viral infection
(e.g. cold sores
‘herpes simplex’, chicken pox) or fungal infection (e.g. tinea,
also called ‘athlete’s
foot’, ringworm or thrush) of the skin.
•
on your face or near your eyes, on the anal or genital region, or on
broken skin.
TAKE SPECIAL CARE WITH CORTOPIN 1% W/W CREAM
Cortopin 1% w/w Cream is NOT suitable for use i

Ապրանքի հատկությունները

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Cortopin 1% w/w Cream
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
The cream contains Hydrocortisone 1% w/w.
Also contains 7.2% w/w Cetostearyl alcohol and 0.1% w/w Chlorocresol
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cream
A smooth, white, homogenous oil in water cream.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
It can be used to treat contact and allergic dermatitis irritant,
insect bite reactions and mild to moderate eczema.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For topical use.
Adults and children over 12 years:
For use on the skin only. Hands should be washed before and after use.
Apply sparingly once or twice a day to the
affected area, or as directed by the physician. Do not use for more
than 7 days.
Children:
Do not use on children under 12 years of age unless under medical
supervision. If symptoms persist consult your
doctor.
Do not use on the anal or genital region, or on broken or infected
skin.
Do not use on the face except if the doctor has advised you. Do not
get the cream in your eyes.
4.3 CONTRAINDICATIONS
Use in the presence of untreated infections of bacterial, viral,
tuberculous or fungal origin.
Use in acne vulgaris, acne rosacea or in perioral dermatoses.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Side effects include local irritation, hypersensitivity and
intercurrent infections.
Continuous treatment for longer than three weeks should be avoided in
patients under the age of three years because of
the possibility of adrenocortical suppression or of growth
suppression.
Prolonged use of uninterrupted occlusion or use with extensive
occlusive dressings including napkin may suppress
adrenocortical function.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_